[Hypoglycemia controlled by diazoxide in a case of malignant cholangioma].
D002759:Adenoma, Bile Duct / Q000150:complications*; D001539:Bendroflumethiazide / Q000627:therapeutic use; D002395:Catecholamines / Q000502:physiology; D003981:Diazoxide / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D005934:Glucagon; D005951:Glucose Tolerance Test; D006801:Humans; D007003:Hypoglycemia / Q000517:prevention & control*; D007328:Insulin; D007930:Leucine; D008875:Middle Aged; D011984:Sensory Receptor Cells / Q000187:drug effects; D014044:Tolbutamide
D002395:Catecholamines; D007328:Insulin; D001539:Bendroflumethiazide; D005934:Glucagon; D014044:Tolbutamide; D007930:Leucine; D003981:Diazoxide
Hypoglycémies accompagnant un cholangiome malin contrôlées par le diazoxide.